| Variables |
HIV-ve n=63 |
HIV+ve not on treatment n=54 |
HIV+ve on treatment n=52 |
P-value ANOVA |
| Age in years |
30.34±10.646 |
36.25±10.785 |
40.21±9.554 |
<0.000 |
| Weight(kg m) |
71.35± 15.45 |
71.31±19.64 |
68.50±13.72 |
0.583 |
| Height(cm) |
164.77± 8.40 |
162.87±7.61 |
162.72±8.03 |
0.322 |
| WC (cm) |
85.43± 15.32 |
85.84±21.41 |
90.39±10.58 |
0.209 |
| HC (cm) |
105.44±14.02 |
102.12±13.94 |
103.69±10.30 |
0.439 |
| BMI (kgm/m2) |
33.10± 38.57 |
26.38± 5.80 |
25.78± 4.79 |
0.17 |
| WHR (%) |
0.83±0.09 |
0.80±0.19 |
0.88±0.21 |
0.13 |
| SBP(mm/hg) |
121.25±14.52 |
123.40± 21.99 |
126.44± 17.83 |
0.312 |
| DBP(mm/hg) |
79.72± 9.57 |
82.88± 12.05 |
84.63± 11.60 |
0.059 |
| PBP(mm/hg) |
75.43± 11.88 |
77.29± 18.27 |
79.33± 18.69 |
0.458 |
| HR(b/min) |
67.58± 9.50 |
73.31± 11.54 |
72.83±14.40 |
0.017 |
| MP(mm/hg) |
92.76± 15.34 |
98.22±11.25 |
97.33±12.62 |
0.063 |
| ED(%) |
33.71±3.80 |
36.31± 3.56 |
36.15± 4.431 |
0.001 |
| AIx(75) |
15.56±13.20 |
19.92± 12.20 |
21.87± 12.26 |
0.024 |
| SEVR(%) |
176.16±29.55 |
155.04± 24.55 |
159.80±28.559 |
0 |
| In all the participants not differentiating the ages HR, AIx(75).SEVR%,ED%within the three groups of participants |
|
